HEADER ISOMERASE 25-APR-07 2UZ5 TITLE SOLUTION STRUCTURE OF THE FKBP-DOMAIN OF LEGIONELLA PNEUMOPHILA MIP COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE INFECTIVITY POTENTIATOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FKBP DOMAIN, RESIDUES 97-233; COMPND 5 EC: 5.2.1.8; COMPND 6 OTHER_DETAILS: NMR SOLUTION STRUCTURE OF THE MONOMERIC FKBP-DOMAIN OF COMPND 7 MIP. IN THE REFERENCES THE N-TERMINAL 20 AMINO ACID SIGNAL SEQUENCE COMPND 8 IS MISSING (ALL AMINO ACID NUMBERS THERE ARE MODIFIED WITH -20) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEGIONELLA PNEUMOPHILA; SOURCE 3 ORGANISM_TAXID: 446; SOURCE 4 OTHER_DETAILS: SURFACE EXPOSED PROTEIN KEYWDS ISOMERASE, FKBP, LEGIONELLA PNEUMOPHILA, PPIASE, LEGIONNAIRES DISEASE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.CEYMANN,M.HORSTMANN,P.EHSES,K.SCHWEIMER,M.STEINERT,T.KAMPHAUSEN, AUTHOR 2 G.FISCHER,J.HACKER,P.ROSCH,C.FABER REVDAT 3 14-JUN-17 2UZ5 1 REMARK REVDAT 2 24-FEB-09 2UZ5 1 VERSN REVDAT 1 12-JUN-07 2UZ5 0 JRNL AUTH M.HORSTMANN,P.EHSES,K.SCHWEIMER,M.STEINERT,T.KAMPHAUSEN, JRNL AUTH 2 G.FISCHER,J.HACKER,P.ROSCH,C.FABER JRNL TITL DOMAIN MOTIONS OF THE MIP PROTEIN FROM LEGIONELLA JRNL TITL 2 PNEUMOPHILA JRNL REF BIOCHEMISTRY V. 45 12303 2006 JRNL REFN ISSN 0006-2960 JRNL PMID 17014083 JRNL DOI 10.1021/BI060818I REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.HORSTMANN,T.KAMPHAUSEN,K.SCHWEIMER,M.STEINERT,J.HACKER, REMARK 1 AUTH 2 A.HAASE,P.ROSCH,G.SCHWEIMER,C.FABER REMARK 1 TITL 1H, 13C, 15N BACKBONE AND SIDECHAIN RESONANCE ASSIGNMENT OF REMARK 1 TITL 2 MIP(77-213) THE PPIASE DOMAIN OF THE LEGIONELLA PNEUMOPHILA REMARK 1 TITL 3 MIP PROTEIN REMARK 1 REF J.BIOMOL.NMR V. 31 77 2005 REMARK 1 REFN ISSN 0925-2738 REMARK 1 PMID 15692747 REMARK 1 DOI 10.1007/S10858-004-6041-6 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA/CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2UZ5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-APR-07. REMARK 100 THE DEPOSITION ID IS D_1290032240. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 90% WATER/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : VARIOUS REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AM REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW, ARIA, CNS, REMARK 210 PYMOL, MANY OTHERS OTHERS REMARK 210 METHOD USED : ARIA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY ON 13C, 15N-LABELED MIP AND UNLABELLED RAPAMYCIN. REMARK 210 THE STRUCTURES ARE SORTED BY ENERGY REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 20 -19.75 -46.66 REMARK 500 1 ILE A 37 -60.83 -101.21 REMARK 500 1 ASN A 41 -83.07 70.08 REMARK 500 1 LYS A 44 157.64 165.46 REMARK 500 1 LYS A 47 -13.46 -41.33 REMARK 500 1 ASP A 66 131.17 -176.51 REMARK 500 1 SER A 97 -175.92 -67.75 REMARK 500 1 THR A 98 97.75 -161.54 REMARK 500 1 ALA A 108 -104.31 -109.93 REMARK 500 1 PRO A 111 -7.05 -57.99 REMARK 500 1 SER A 113 14.24 -63.25 REMARK 500 1 LYS A 134 64.96 34.37 REMARK 500 2 LYS A 20 -19.99 -43.22 REMARK 500 2 ILE A 37 -65.69 -101.90 REMARK 500 2 ASN A 41 -57.39 -177.93 REMARK 500 2 LYS A 44 156.87 164.65 REMARK 500 2 LYS A 47 -13.18 -41.26 REMARK 500 2 ASP A 66 130.15 -175.68 REMARK 500 2 ALA A 108 -125.11 -127.73 REMARK 500 2 VAL A 114 55.21 -111.09 REMARK 500 2 LYS A 134 -149.07 38.50 REMARK 500 2 SER A 136 67.03 65.43 REMARK 500 3 LYS A 20 -19.85 -46.71 REMARK 500 3 ILE A 37 -66.70 -103.63 REMARK 500 3 ASN A 41 -82.29 -151.48 REMARK 500 3 LYS A 44 155.24 165.92 REMARK 500 3 LYS A 47 -13.22 -41.71 REMARK 500 3 ASP A 66 130.74 -177.25 REMARK 500 3 ALA A 108 -104.17 -109.19 REMARK 500 3 PRO A 111 -6.52 -58.62 REMARK 500 3 SER A 113 11.85 -63.00 REMARK 500 4 LYS A 20 -20.00 -46.02 REMARK 500 4 ILE A 37 -64.10 -104.60 REMARK 500 4 ASN A 38 78.60 -151.26 REMARK 500 4 ASN A 41 -62.10 -176.48 REMARK 500 4 LYS A 44 156.29 163.71 REMARK 500 4 LYS A 47 -13.20 -41.61 REMARK 500 4 ASP A 66 129.50 -175.82 REMARK 500 4 ALA A 108 -104.10 -109.18 REMARK 500 4 SER A 113 -0.60 -55.71 REMARK 500 4 LYS A 134 73.16 33.36 REMARK 500 5 LYS A 20 -18.58 -48.04 REMARK 500 5 VAL A 25 109.48 -58.65 REMARK 500 5 ILE A 37 -66.82 -107.22 REMARK 500 5 ASN A 41 -62.28 -177.75 REMARK 500 5 LYS A 44 156.20 164.94 REMARK 500 5 LYS A 47 -13.50 -41.41 REMARK 500 5 ASP A 66 130.05 -175.91 REMARK 500 5 ALA A 108 -104.36 -109.10 REMARK 500 5 PRO A 111 -6.96 -58.80 REMARK 500 REMARK 500 THIS ENTRY HAS 98 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 999 REMARK 999 SEQUENCE REMARK 999 ONLY RESIDUES 97-233 INCLUDED DBREF 2UZ5 A 1 137 UNP Q933L8 Q933L8_LEGPN 97 233 SEQRES 1 A 137 PHE ASN LYS LYS ALA ASP GLU ASN LYS VAL LYS GLY GLU SEQRES 2 A 137 ALA PHE LEU THR GLU ASN LYS ASN LYS PRO GLY VAL VAL SEQRES 3 A 137 VAL LEU PRO SER GLY LEU GLN TYR LYS VAL ILE ASN SER SEQRES 4 A 137 GLY ASN GLY VAL LYS PRO GLY LYS SER ASP THR VAL THR SEQRES 5 A 137 VAL GLU TYR THR GLY ARG LEU ILE ASP GLY THR VAL PHE SEQRES 6 A 137 ASP SER THR GLU LYS THR GLY LYS PRO ALA THR PHE GLN SEQRES 7 A 137 VAL SER GLN VAL ILE PRO GLY TRP THR GLU ALA LEU GLN SEQRES 8 A 137 LEU MET PRO ALA GLY SER THR TRP GLU ILE TYR VAL PRO SEQRES 9 A 137 SER GLY LEU ALA TYR GLY PRO ARG SER VAL GLY GLY PRO SEQRES 10 A 137 ILE GLY PRO ASN GLU THR LEU ILE PHE LYS ILE HIS LEU SEQRES 11 A 137 ILE SER VAL LYS LYS SER SER HELIX 1 1 PHE A 1 LYS A 20 1 20 HELIX 2 2 SER A 80 GLN A 81 5 2 HELIX 3 3 PRO A 84 GLN A 91 1 8 HELIX 4 4 PRO A 104 ALA A 108 5 5 SHEET 1 AA 5 GLN A 33 ASN A 38 0 SHEET 2 AA 5 THR A 98 TYR A 102 -1 O THR A 98 N ILE A 37 SHEET 3 AA 5 ILE A 125 VAL A 133 -1 O PHE A 126 N ILE A 101 SHEET 4 AA 5 THR A 50 ARG A 58 -1 O THR A 52 N ILE A 131 SHEET 5 AA 5 ALA A 75 GLN A 78 -1 O ALA A 75 N VAL A 53 SHEET 1 AB 5 GLN A 33 ASN A 38 0 SHEET 2 AB 5 THR A 98 TYR A 102 -1 O THR A 98 N ILE A 37 SHEET 3 AB 5 ILE A 125 VAL A 133 -1 O PHE A 126 N ILE A 101 SHEET 4 AB 5 THR A 50 ARG A 58 -1 O THR A 52 N ILE A 131 SHEET 5 AB 5 VAL A 64 SER A 67 -1 N PHE A 65 O GLY A 57 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1